Using advanced protein biomarker approaches to better understand COVID-19
Webinar title: "Using advance protein biomarker approaches to better understand rare disease and COVID-19"
In this webinar, Dr. Frank Schmidt discusses two clinical studies run by the Weill Cornell Medicine Proteomics core using Olink protein assays to understand COVID-19. These two studies were then included in an inter-study comparison to find commonalities in the findings of important protein biomarkers in the disease.
Watch the webinar to learn more about:
- Dr. Schmidt's discovery that the same inflammatory proteins were elevated in patients suffering from ARDS resulting from COVID-19, influenza, and bacterial sepsis
- How Dr Schmidt combined metabolomic and proteomic data to compare patients who were hospitalized due to COVID-19 vs another disease
- Their findings of 37 proteins that were common in all five clinical studies that were compared in their meta analysis
Speaker
![FRANKSBW2 FRANKSBW2](https://info.olink.com/hubfs/FRANKSBW2.png)
Dr. Frank Schmidt
Associate Professor of Biochemistry, Weill Cornell Medical College, Qatar